IRIS
DE MURO, Pierina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.734
EU - Europa 1.114
AS - Asia 617
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
SA - Sud America 6
AF - Africa 4
Totale 3.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.724
CN - Cina 528
UA - Ucraina 510
DE - Germania 171
IT - Italia 116
SE - Svezia 92
FI - Finlandia 83
FR - Francia 66
GB - Regno Unito 42
SG - Singapore 36
TR - Turchia 26
BE - Belgio 20
KR - Corea 18
CA - Canada 9
EU - Europa 8
AU - Australia 6
BR - Brasile 5
CZ - Repubblica Ceca 3
IL - Israele 3
JP - Giappone 3
PL - Polonia 3
EG - Egitto 2
HR - Croazia 2
AO - Angola 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.490
Salva come PNG Salva come JPEG
Città #
Chandler 435
Jacksonville 316
Princeton 158
Nanjing 147
Dearborn 104
Ann Arbor 83
Wilmington 72
Nanchang 65
New York 60
Sassari 59
Boardman 43
Beijing 42
Shenyang 42
Hebei 39
Woodbridge 31
Changsha 30
Ningbo 26
Tianjin 23
Izmir 22
Mountain View 22
Hangzhou 21
Singapore 21
Brussels 20
Jinan 19
Seoul 18
Jiaxing 17
Zhengzhou 17
Kunming 14
Andover 13
Norwalk 13
Ashburn 10
Toronto 8
Guangzhou 7
San Francisco 7
Villiers-sur-marne 7
Auburn Hills 6
Helsinki 6
Lanzhou 6
Los Angeles 6
Taizhou 6
Changchun 5
Brno 3
Falls Church 3
Melbourne 3
Paris 3
Verona 3
Warsaw 3
Cagliari 2
Cairo 2
Canberra 2
Cedar Knolls 2
Edinburgh 2
Fairfield 2
Hanover 2
London 2
San Jose 2
San Mateo 2
Santa Clara 2
Serramanna 2
São Paulo 2
Tappahannock 2
Tel Aviv 2
Tokyo 2
Turin 2
Zagreb 2
Adelaide 1
Agadir 1
Americo Brasiliense 1
Amsterdam 1
Augusta 1
Bangkok 1
Berlin 1
Chernihiv 1
Denver 1
Ficarazzi 1
Fredericton 1
Haifa 1
Haikou 1
Hanoi 1
Leawood 1
Ljubljana 1
Mexico City 1
Miami 1
Milan 1
Munich 1
New Plymouth 1
Oristano 1
Potenza 1
Rome 1
Sofia 1
Totale 2.145
Salva come PNG Salva come JPEG
Nome #
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 73
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 72
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 68
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 63
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 63
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 62
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 62
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 62
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 61
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 60
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 59
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 58
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 56
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 54
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 53
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 53
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 52
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 52
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 51
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 50
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 50
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 50
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 50
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 49
Urinary excretion of GAGs during hypocholesterolemic therapy 49
Apolipoprotein Profiles in Atherosclerotic Disease 47
Role of the small proteoglycan bikunin in human reproduction 46
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 46
Buoyant density of Lp(a) subclasses in hypercholesterolemia 46
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 45
Apolipoprotein Profiles in Atherosclerotic Disease 44
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 44
GAG and protein composition of GAG-protein complexes from normal human plasma 43
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 43
Atherosclerotic modifications of human proteoglycans 43
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 43
Proteoglicani e diabete gestazionale: dati preliminari 43
Urinary transaforming growth factor beta 1 in various types of nephropathy 42
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 42
Ruolo dei proteoglicani nella medicina della riproduzione 42
Urinary glycosaminoglycan composition in chronic glomerulonephritis 42
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 41
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 41
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 41
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 40
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 40
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 40
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 39
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 39
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 39
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 39
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 38
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 38
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 38
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 38
The gamma globin chain heterogeneity of the Sardinian newborn baby 37
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 37
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 37
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 36
Glycosamynoglycan diversity in sponge extracellular matrix 36
Urine bikunin as a marker of renal impairment in Fabry's disease 36
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 34
Modification of low density lipoprotein induced by the interaction with standard GAGs 34
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 33
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 33
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 33
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 33
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 33
Glycosaminoglycan diversity in sponge extracellular matrix 32
Glycosaminoglycans and fabry’s disease 32
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 31
Urinary transforming growth factor-beta 1 in various types of nephropathy 30
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 30
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 28
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 28
Sulphated polysaccharide content and localization in some marine sponge species. 26
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 26
Totale 3.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020861 236 2 78 8 89 89 133 10 89 31 96 0
2020/2021606 84 5 98 8 82 19 85 4 95 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 3.525